Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry
Dose reduction maintains low recurrence rates but also decreases bleeding, with the most pronounced effect in the cancer population.
Authors
- Damon E. Houghton (ORCID: https://orcid.org/0000-0002-6065-9523)
- Teresa Lang
- Lisa Peterson (ORCID: https://orcid.org/0009-0002-5307-0216)
- Robert D. McBane (ORCID: https://orcid.org/0000-0001-8727-8029)
- Waldemar E. Wysokiński (ORCID: https://orcid.org/0000-0002-8119-6206)
- Danielle T. Vlazny (ORCID: https://orcid.org/0000-0001-7074-6391)
- David O. Hodge (ORCID: https://orcid.org/0000-0001-5148-9174)
- Ana I. Casanegra (ORCID: https://orcid.org/0000-0001-6114-4284)
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1016/j.rpth.2025.102878
- Citations
- 3
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.61